Brent Vaughan is the founder of Cognito Therapeutics. Cognito Therapeutics has raised $93M in total funding. Latest round: Series B.
Brent Vaughan is the CEO and Co-Founder of Cognito Therapeutics, a company based in Cambridge, Massachusetts. He has overseen the company's progression from Phase 2 to a Phase 3 clinical trial for a non-invasive neuromodulation device for Alzheimer's disease.
Full founder directory · Investor directory · Company funding database · Fundraising library